Escalating federal healthcare costs and a 310-fold increase in pediatric GLP-1 prescriptions highlight a growing tension between pharmaceutical innovation and fiscal sustainability.
Recent FDA recalls for Mexican jalapeños and imported superfoods coincide with EPA moves to rescind key drinking water standards, leaving local communities to navigate a complex landscape of contamination risks.
A historic Ebola surge in the DR Congo is forcing a massive $1.3 billion funding request, testing the efficacy of international pandemic surveillance and American-backed development initiatives.
Upcoming federal reports will reveal the state of American poverty as low-income households face new work requirements and a looming September budget disruption.
As the CLARITY Act stalls in the Senate, Bitcoin’s decentralized infrastructure faces a shifting regulatory landscape defined by SEC rule-making and macro-economic debt buybacks.
Researchers at the LUX-ZEPLIN experiment have identified a rare particle interaction that could finally unveil the universe’s missing mass.
New federal mandates and congressional legislation aim to dismantle administrative barriers in Medicare Advantage, forcing insurers to accelerate care approvals and increase transparency.
Physicists report a compelling dark matter candidate from the LUX-ZEPLIN experiment alongside breakthroughs in exotic particles and quantum materials that challenge existing models of reality.
The Commodity Futures Trading Commission remains crippled by four vacancies despite rising global bond yields and oil prices, leaving a single commissioner to oversee critical derivatives markets.
